Mcmaster University
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1887-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.mcmaster.ca
ERA 2025 to Feature Pivotal Nephrology Trials Including CONFIDENCE, ACHIEVE, and VISIONARY Studies
The 62nd European Renal Association Congress in Vienna will present seven late-breaking clinical trials addressing chronic kidney disease, dialysis patients, and glomerular disease developments.
CLEAR OASIS 9 Trial: Colchicine and Spironolactone Show Limited Benefits After Myocardial Infarction
Late-breaking results from the CLEAR OASIS 9 trial reveal that colchicine failed to reduce cardiovascular events after myocardial infarction despite lowering inflammatory markers.
New Antibiotic Class Discovered in Soil Sample Could Combat Drug-Resistant Bacteria
Researchers have identified lariocidin, the first new class of antibiotics to reach the market in nearly 30 years, discovered in bacteria from backyard soil samples.
McMaster University Launches Phase-2 Trial of Novel Inhaled COVID-19 Vaccine
Canadian researchers at McMaster University have begun phase-2 clinical trials for AeroVax, an innovative inhaled COVID-19 vaccine that directly targets the lungs and upper airways where infection begins.
Global Study Reveals Critical Underutilization of Secondary Prevention Medications for Cardiovascular Disease
A comprehensive 12-year PURE study across 17 countries shows significant underutilization of secondary prevention medications for cardiovascular disease, with usage rates dropping to 31.3% in the final study visit.